Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valdemar Priebe
Observed names:
PRIEBE, VALDEMAR,
Priebe, Valdemar,
V. Priebe
Institutions:
University of Zurich,
Institute of Oncology Research,
University Children's Hospital Zurich,
Università della Svizzera italiana
Observed institutions:
University of Zurich,
Karolinska Institutet,
Institute of Oncology Research,
University Children's Hospital Zurich,
Istituto Oncologico della Svizzera Italiana,
Università della Svizzera italiana
show all 6
ORCID:
0000-0002-8763-0026
Observed ORCID:
0000-0002-8763-0026
OpenAlex ID:
A5077930649
Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734
2020
·
Filippo Spriano
, Eugenio Gaudio
, et al.
·
Blood Advances
·
79
The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
2019
·
Filippo Spriano
, Elaine Yee Lin Chung
, et al.
·
Clinical Cancer Research
·
70
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma
2019
·
Binu K. Sasi
, Claudio Martines
, et al.
·
Leukemia
·
36
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors
2021
·
Afua Adjeiwaa Mensah
, Filippo Spriano
, et al.
·
Blood Advances
·
26
PDF
Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma
2014
·
Agata M. Wasik
, Valdemar Priebe
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
24
The transcription factor ETS1 in lymphomas: friend or foe?
2014
·
Monica Testoni
, Elaine Yee Lin Chung
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
23
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas
2019
·
Filippo Spriano
, Chiara Tarantelli
, et al.
·
British Journal of Haematology
·
18
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents
2019
·
Chiara Tarantelli
, Lu Zhang
, et al.
·
Haematologica
·
18
PDF
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
2021
·
Giulio Sartori
, Sara Napoli
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
17
PDF
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type
2020
·
Valdemar Priebe
, Giulio Sartori
, et al.
·
Cancers
·
11
PDF
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG
2023
·
Eitan Kugler
, Shreyas Madiwale
, et al.
·
Nature Communications
·
9
PDF
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells
2023
·
Elaine Y. L. Chung
, Giulio Sartori
, et al.
·
British Journal of Haematology
·
5
PDF
TCF3::HLF orchestrates an enhancer-promoter network with activation of MEF2C to promote immature HSC gene expression in leukemia
2026
·
Valdemar Priebe
, Bartimée Galvan
, et al.
·
Science Advances
·
3
PDF
SHP1 Deficiency Is Responsible for the Constitutive Activation of the BCR Pathway in GCB DLBCL
2018
·
Binu K Sasi
, Sven Turkalj
, et al.
·
Blood
·
2
P331: the Oncogenic Transcription Factor Tcf3::hlf Marks a Distinct Enhancer-promoter Interaction Network in T(17;19) Positive Childhood Acute Lymphoblastic Leukemia
2023
·
Valdemar Priebe
, Aneta Drakul
, et al.
·
HemaSphere
·
1
Ets1 Positively Regulates Faim3 in Activated B Cell‐like (abc) Diffuse Large B Cell Lymphoma (dlbcl)
2017
·
V. Priebe
, E.Y. Chung
, et al.
·
Hematological Oncology
·
1
PDF
ETS1 Phosphorylation at Threonine-38 Is a Marker of B Cell Receptor Activation, Associating with Cell of Origin and Outcome in Diffuse Large B Cell Lymphoma
2016
·
Elaine Y Chung
, Maurilio Ponzoni
, et al.
·
Blood
·
1
The RNA helicase DDX21 cooperates with ETS1 and FLI1 in cell cycle, immune evasion, and snoRNA processing in activated B-cell-like diffuse large B-cell lymphoma cells
2026
·
Giulio Sartori
, Valdemar Priebe
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
173 | Fli1 Interactome in Diffuse Large B‐cell Lymphoma Identifies Atg9a as a Novel Autophagy‐related Interactor
2025
·
G. Sartori
, L. Cascione
, et al.
·
Hematological Oncology
PDF
Abstract PO-015: The RNA helicase DDX21 cooperates with ETS1 and FLI1 in cell cycle regulation, immune evasion and small nucleolar RNA processing to sustain the survival of DLBCL cells
2024
·
Giulio Sartori
, Valdemar Priebe
, et al.
·
Blood Cancer Discovery
The RNA helicase DDX21 cooperates with ETS1 and FLI1 in cell cycle regulation and small nucleolar RNA processing to sustain the survival of DLBCL cells
2023
·
G. Sartori
, V. Priebe
, et al.
·
Hematological Oncology
PDF
Table S6 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
2023
·
Filippo Spriano
, Elaine Yee Lin Chung
, et al.
Table S2 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
2023
·
Filippo Spriano
, Elaine Yee Lin Chung
, et al.
Table S4 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
2023
·
Filippo Spriano
, Elaine Yee Lin Chung
, et al.
Table S3 from The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
2023
·
Filippo Spriano
, Elaine Yee Lin Chung
, et al.
Show more works
View as search
Works count:
46
Citation count:
343
H-index:
10
I10-index:
10
Year
Topic
Type